By Ayesha Ayath Aslam
About a week ago, Mpox was declared an international health emergency for the second time in two years. The upsurge of Mpox cases has garnered global concern due to the contagious nature of this infection. So, awareness becomes the key to prevention
Mpox is an infectious disease similar to smallpox. Discovered in the late 1950s, this zoonotic disease is self-limiting (i.e. has a history of resolving itself with or without specific treatment) but can cause severe illness leading to death.
Mpox virus is transmitted through direct face-to-face, skin-to-skin, mouth-to-mouth, or mouth-to-skin contact with an infected person or animal, bodily fluids, or contaminated materials.
Rash (blisters), fever, sore throat, headache, muscle aches, back pain, low energy, swollen lymph nodes, etc. are a few apparent and common symptoms that typically last 2-4 weeks. Notably, few of those infected might show no signs of symptoms.
Mpox can likely mimic other illnesses and conditions, such as chickenpox, herpes, etc. Hence, Mpox must be distinguished and detected through a Polymerase chain reaction (PCR) test.
The people who are most at risk of getting sick are partners and family members. Furthermore, individuals with weakened immune systems, such as youngsters and pregnant people, may experience severe symptoms.
Get tested and vaccinated if accessible. Otherwise, WHO has suggested several other antivirals used for treating smallpox, that can aid treatment of Mpox too. In addition to that, follow necessary public health and social measures. Stay tuned to know the recommended preventative measures.